Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5613)
All Articles published online
|
Publishing Process of This Article
|
Dec 10, 2014 (publication date) through May 11, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Oncology
ISSN
2218-4333
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Georges P, Rajagopalan K, Leon C, Singh P, Ahmad N, Nader K, Kubicek GJ. Chemotherapy advances in locally advanced head and neck cancer. World J Clin Oncol 2014; 5(5): 966-972 [PMID: 25493232 DOI: 10.5306/wjco.v5.i5.966] |
|---|---|
| URL: | https://www.wjgnet.com/2218-4333/full/v5/i5/966.htm |
| Number | Citing Articles |
| 1 |
Christine E. Lehman, Adam Spencer, Sarah Hall, Jeremy J. P. Shaw, Julia Wulfkuhle, Emanuel F. Petricoin, Stefan Bekiranov, Mark J. Jameson, Daniel Gioeli. IGF1R and Src inhibition induce synergistic cytotoxicity in HNSCC through inhibition of FAK. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-90289-1
|
| 2 |
McKenzie Crist, Benyamin Yaniv, Sarah Palackdharry, Maria A Lehn, Mario Medvedovic, Timothy Stone, Shuchi Gulati, Vidhya Karivedu, Michael Borchers, Bethany Fuhrman, Audrey Crago, Joseph Curry, Ubaldo Martinez-Outschoorn, Vinita Takiar, Trisha M Wise-Draper. Metformin increases natural killer cell functions in head and neck squamous cell carcinoma through CXCL1 inhibition. Journal for ImmunoTherapy of Cancer 2022; 10(11): e005632 doi: 10.1136/jitc-2022-005632
|
| 3 |
Chung-I. Huang, Chih-Chun Wang, Tzong-Shyuan Tai, Tzer-Zen Hwang, Chuan-Chien Yang, Chin-Mu Hsu, Yu-Chieh Su, Randall J. Kimple. eIF4E and 4EBP1 are prognostic markers of head and neck squamous cell carcinoma recurrence after definitive surgery and adjuvant radiotherapy. PLOS ONE 2019; 14(11): e0225537 doi: 10.1371/journal.pone.0225537
|
| 4 |
Bishal Gyawali, Tomoya Shimokata, Kazunori Honda, Yuichi Ando. Chemotherapy in locally advanced head and neck squamous cell carcinoma. Cancer Treatment Reviews 2016; 44: 10 doi: 10.1016/j.ctrv.2016.01.002
|
| 5 |
Ulrich Strassen, Benedikt Hofauer, Christian Jacobi, Andreas Knopf. Management of locoregional recurrence in cutaneous squamous cell carcinoma of the head and neck. European Archives of Oto-Rhino-Laryngology 2017; 274(1): 501 doi: 10.1007/s00405-016-4243-7
|
| 6 |
Bianka Gurbi, Diána Brauswetter, Attila Varga, Pál Gyulavári, Kinga Pénzes, József Murányi, Veronika Zámbó, Ede Birtalan, Tibor Krenács, David Laurence Becker, Miklós Csala, István Vályi-Nagy, István Peták, Kornél Dános. The Potential Impact of Connexin 43 Expression on Bcl-2 Protein Level and Taxane Sensitivity in Head and Neck Cancers–In Vitro Studies. Cancers 2019; 11(12): 1848 doi: 10.3390/cancers11121848
|
| 7 |
Trisha Chattopadhyay, Priyajit Biswal, Anthony Lalruatfela, Bibekanand Mallick. Emerging roles of PIWI-interacting RNAs (piRNAs) and PIWI proteins in head and neck cancer and their potential clinical implications. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2022; 1877(5): 188772 doi: 10.1016/j.bbcan.2022.188772
|
| 8 |
Xiaoling Zhang, Joseph Wu, Suju Luo, Terry Lechler, Jennifer Y. Zhang. FRA1 promotes squamous cell carcinoma growth and metastasis through distinct AKT and c-Jun dependent mechanisms. Oncotarget 2016; 7(23): 34371 doi: 10.18632/oncotarget.9110
|
| 9 |
Florian Gaertner, Saskia Preissner, Max Heiland, Robert Preissner, Jonas Wüster. Beneficial Effect of Metformin on the Five-Year Survival in about 40,000 Patients with Head and Neck Cancer. Cancers 2024; 16(5): 982 doi: 10.3390/cancers16050982
|
| 10 |
Christine E. Lehman, Ashraf A. Khalil, Mark J. Axelrod, Michael I. Dougherty, Stephen S. Schoeff, Linnea E. Taniguchi, Rolando E. Mendez, Abel P. David, Patrick O. McGarey, Matthew A. Hubbard, Lane Donaldson, Henry F. Frierson, Edward B. Stelow, Stefan Bekiranov, Julia D. Wulfkuhle, Emanuel F. Petricoin, Daniel G. Gioeli, Mark J. Jameson. Antitumor effect of insulin‐like growth factor‐1 receptor inhibition in head and neck squamous cell carcinoma. The Laryngoscope 2020; 130(6): 1470 doi: 10.1002/lary.28236
|
| 11 |
Kiyoshi Misawa, Daiki Mochizuki, Atsushi Imai, Shiori Endo, Masato Mima, Yuki Misawa, Takeharu Kanazawa, Thomas E. Carey, Hiroyuki Mineta. Prognostic value of aberrant promoter hypermethylation of tumor-related genes in early-stage head and neck cancer. Oncotarget 2016; 7(18): 26087 doi: 10.18632/oncotarget.8317
|
| 12 |
Hendrik Setia Budi, Bagher Farhood. Tumor microenvironment remodeling in oral cancer: Application of plant derived-natural products and nanomaterials. Environmental Research 2023; 233: 116432 doi: 10.1016/j.envres.2023.116432
|
| 13 |
Ching‐Chou Tsai, Jian‐Tai Qiu, Chih‐Wen Tseng, Yi‐Chiang Hsu. Low‐dose metronomic chemotherapy with cisplatin enhanced immunity in a murine model of ectopic cervical cancer. Clinical and Experimental Pharmacology and Physiology 2016; 43(2): 251 doi: 10.1111/1440-1681.12515
|